Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: A retrospective multicenter survey

Tohoku Journal of Experimental Medicine

Volumn 233, Issue 2, 2014, Pages 129-133

  Watanabe, Ryu ^a   Ishii, Tomonori ^a   Kobayashi, Hiroko ^b   Asahina, Ichizo ^c   Takemori, Hiromitsu ^d   Izumiyama, Tomomasa ^e   Oguchi, Yoshito ^f   Urata, Yukitomo ^g   Nishimaki, Tomoe ^h   Chiba, Katsumi ⁱ   Komatsuda, Atsushi ^j   Chiba, Noriyuki ^k   Miyata, Masayuki ^l   Takagi, Michiaki ^m   Kawamura, Osamu ⁿ   Kanno, Takashi ^o   Hirabayashi, Yasuhiko ^p   Konta, Tsuneo ^q   Ninomiya, Yukari ^r   Abe, Yoshiyuki ^s   Murata, Yuhji ^t   Saito, Yoshihiro ^u   Ohira, Hiromasa ^b   Harigae, Hideo ^a   Sasaki, Takeshi ^v   more..

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c Yamagata Prefectural Central Hospital   (Japan)

^d AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e Higashisendai Riumatikanaika Clinic   (Japan)

^f Oguchi Clinic Koriyama   (Japan)

^g Department of Rheumatology Seihoku Central Hospital   (Japan)

^h Nishimaki Clinic   (Japan)

ⁱ Fukushima Daiichi Hospital   (Japan)

^j AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k Japan   (Japan)

^l Fukushima Red Cross Hospital   (Japan)

^m Department of Orthopaedic surgery ^*  (Japan)

ⁿ JAPANESE RED CROSS SOCIETY   (Japan)

^o OHTA NISHINOUCHI HOSPITAL   (Japan)

^p Hikarigaoka Spellman Hospital   (Japan)

^q YAMAGATA UNIVERSITY   (Japan)

^r Ninomiya Medical Clinic   (Japan)

^s Yamagata Prefectural Shinjo Hospital   (Japan)

^t Kuroishi General Hospital   (Japan)

^u Saito Clinic   (Japan)

^v NTT East Tohoku Hospital   (Japan)

more..

Author keywords

Hepatitis B Virus; Immunosuppressive therapy; Rheumatoid arthritis; Screening; Systemic lupus erythematosus

Indexed keywords

BIOLOGICAL PRODUCT; ENTECAVIR; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; METHOTREXATE; PREDNISOLONE; BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; JAPAN; MAJOR CLINICAL STUDY; PREVALENCE; QUESTIONNAIRE; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; HEPATITIS B VIRUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MASS SCREENING; MULTICENTER STUDY; PHYSIOLOGY; RHEUMATIC DISEASES; VIROLOGY;

BIOLOGICAL MARKERS; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MASS SCREENING; PREVALENCE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES;

EID: 84901918014     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.233.129     Document Type: Article

References (20)

1. Aletaha, D., Neogi, T., Silman, A.J., Funovits, J., Felson, D.T., Bingham, C.O. 3rd., Birnbaum, N.S., Burmester, G.R., Bykerk, V.P., Cohen, M.D., Combe, B., Costenbader, K.H., Dougados, M., Emery, P., Ferraccioli, G., et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum., 62, 2569-2581.
2. Arnett, F.C., Edworthy, S.M., Bloch, D.A., McShane, D.J., Fries, J.F., Cooper, N.S., Healey, L.A., Kaplan, S.R., Liang, M.H., Luthra, H.S., Medsger, T.A., Mitchell, D.M., Neustadt, D.H., Pinals, R.S., Schaller, J.G., et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 31, 315-324.
3. Day, F.L., Karnon, J. & Rischin, D. (2011a) Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors. J. Clin. Oncol., 29, 3270-3277.
4. Day, F.L., Link, E., Thursky, K. & Rischin, D. (2011b) Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors: a nationwide survey of medical oncologists. J. Oncol. Pract., 7, 141-147.
5. Harigai, M., Mochida, S., Mimura, T., Koike, T. & Miyasaka, N. (2014) A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy. Mod. Rheumatol., 24, 1-7.
6. Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum., 40, 1725.
7. Hwang, J.P., Fisch, M.J., Zhang, H., Kallen, M.A., Routbort, M.J., Lal, L.S., Vierling, J.M. & Suarez-Almazor, M.E. (2012) Low rates of hepatitis B virus screening at the onset of chemotherapy. J. Oncol. Pract., 8, e32-39.
8. Kiyosawa, K., Tanaka, E., Sodeyama, T., Yoshizawa, K., Yabu, K., Furuta, K., Imai, H., Nakano, Y., Usuda, S., Uemura, K., Furuta, S., Watanabe, Y., Watanabe, J., Fukuda, Y. & Takayama, T.; the South Kiso Hepatitis Study Group (1994) Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. Gastroenterology, 106, 1596-1602.
9. Lee, R.S., Bell, C.M., Singh, J.M. & Hicks, L.K. (2012) Hepatitis B screening before chemotherapy: a survey of practitioners' knowledge, beliefs, and screening practices. J. Oncol. Pract., 8, 325-328.
10. Mori, S. (2011) Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs. Mod. Rheumatol., 21, 621-627.
11. Oketani, M., Ido, A., Uto, H. & Tsubouchi, H. (2012) Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy. Hepatol. Res., 42, 627-636.
12. Singh, J.A., Furst, D.E., Bharat, A., Curtis, J.R., Kavanaugh, A.F., Kremer, J.M., Moreland, L.W., O'Dell, J., Winthrop, K.L., Beukelman, T., Bridges, S.L. Jr., Chatham, W.W., Paulus, H.E., Suarez-Almazor, M., Bombardier, C., et al. (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res., 64, 625-639.
13. Stine, J.G., Khokhar, O.S., Charalambopoulos, J., Shanmugam, V.K. & Lewis, J.H. (2010) Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy. Arthritis Care Res., 62, 704-711.
14. Tanaka, J., Koyama, T., Mizui, M., Uchida, S., Katayama, K., Matsuo, J., Akita, T., Nakashima, A., Miyakawa, Y. & Yoshizawa, H. (2011) Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age-and area-specific prevalence on the national scale. Intervirology, 54, 185-195.
15. Tran, T.T., Rakoski, M.O., Martin, P. & Poordad, F. (2010) Screening for hepatitis B in chemotherapy patients: survey of current oncology practices. Aliment. Pharmacol. Ther., 31, 240-246.
16. Umemura, T., Tanaka, E., Kiyosawa, K. & Kumada, H. (2008) Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin. Infect. Dis., 47, e52-56.
17. Urata, Y., Uesato, R., Tanaka, D., Kowatari, K., Nitobe, T., Nakamura, Y. & Motomura, S. (2011) Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients. Mod. Rheumatol., 21, 16-23.
18. Watanabe, R., Ishii, T., Nakamura, K., Shirai, T., Tajima, Y., Fujii, H. & Harigae, H. (2013) Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy. Mod. Rheumatol., 23, 1094-1100.
19. Weinbaum, C.M., Williams, I., Mast, E.E., Wang, S.A., Finelli, L., Wasley, A., Neitzel, S.M. & Ward, J.W. (2008) Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm. Rep., 57, 1-20.
20. Zurawska, U., Hicks, L.K., Woo, G., Bell, C.M., Krahn, M., Chan, K.K. & Feld, J.J. (2012) Hepatitis B virus screening before chemotherapy for lymphoma: a cost-effectiveness analysis. J. Clin. Oncol., 30, 3167-3173.